Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Isoproterenol and Ribose

supplement:

Ribose

Research Papers that Mention the Interaction

infusion of ribose (200 mg/kg/h) in isoproterenol-treated rats prevented the decrease of the cardiac ATP concentration induced by isoproterenol.
Basic Research in Cardiology  •  2005  |  View Paper
The myocardial cell damage induced by isoproterenol was prevented by ribose.
Cardiovascular Drugs and Therapy  •  2004  |  View Paper
The stimulatory effect of isoproterenol on myocardial adenine nucleotide biosynthesis could be further potentiated by ribose and xylitol, but not by glucose.
Pflügers Archiv  •  2004  |  View Paper
Isoproterenol and GTP increased [3H]cyclic ADP‐ribose formation in crude membrane‐associated cyclase activity.
Journal of neurochemistry  •  2000  |  View Paper
Continuous iv infusion of ribose for 5 h in unanesthetized and unrestrained rats treated with isoproterenol (25 mg/kg sc) further enhanced the available pool of 5-phosphoribosyl-1-pyrophosphate and the biosynthesis of adenine nucleotides in the myocardium.
The American journal of physiology  •  1983  |  View Paper
Continuous intravenous infusion of ribose (200 milligrams per kilogram per hour) for 24 hours induced a marked stimulation of cardiac adenine nucleotide biosynthesis in unanesthetized and unrestrained rats that had been treated with isoproterenol subcutaneously (25 milligrams per kilogram).
The diminution of adenine nucleotides characteristic for the action of high doses of isoproterenol was entirely prevented, and the incidence of the isoproterenol-induced myocardial cell damage was significantly reduced when ribose was administered.
Science  •  1980  |  View Paper